Muscle hypertrophy occurs when the rate of protein synthesis exceeds the rate of degradation. A main factor determining the rate of protein synthesis is ribosome abundance or translational capacity. The production of ribosomes is a primary determinant of translational capacity. Based on studies from our laboratory, we propose the novel hypothesis that ribosome biogenesis is necessary for skeletal muscle hypertrophy. Key Words: skeletal muscle, hypertrophy, ribosome, translational capacity, protein synthesis
INTRODUCTION
The adult skeletal muscle as an organ is amazingly plastic. Muscle robustly changes its size, composition, and metabolic profile to adapt optimally to environmental and physiological demands (4) . In response to resistance exercise (RE) training, muscle progressively accumulates protein mass leading to hypertrophy of individual myofibers. Conversely, under chronic conditions of energy deprivation, unloading, and/or disease, muscle undergoes a relatively rapid atrophy resulting from a loss in myofiber cross-sectional area. A critical determinant of muscle mass is the ratio of protein synthesis to protein breakdown; however, commitment to protein synthesis may be the preferred target of regulation in all but emergency situations (22) .
Protein synthesis does not happen without ribosomes, which are nature's nanomachines that convert mRNA genetic code into polypeptide chains. Changes to these protein factories during periods of muscle growth are key to understanding the mechanisms of skeletal muscle plasticity. Specifically, during muscle hypertrophy the amount of protein synthesis per unit RNA (translation efficiency) and the total ribosomal content (translation capacity) both increase within muscle fibers (2, 20) . As one would imagine, these two processes are intimately connected, and, as has been reported in the heart, there is an emerging recognition that the initial increase in translational efficiency in response to a growth stimulus is required for the subsequent increase in translational capacity that ultimately leads to the protein accretion that underlies skeletal muscle hypertrophy (16) .
In this article, we first provide a brief description of the ribosome and the regulation of ribosome biogenesis followed by a discussion of our work supporting the main thesis and then finish with a review of studies from other investigators in the field that provide additional compelling evidence in support of our hypothesis that ribosome biogenesis is necessary for skeletal muscle hypertrophy.
RIBOSOME BIOGENESIS
The functionally mature human ribosome (80S) is a 4.3-Md ribonucleoprotein complex composed of two subunits. The large (60S) subunit contains three (28S, 5S, and 5.8S) ribosomal RNA (rRNA) and 47 ribosomal proteins (RPL). The small (40S) subunit contains one (18S) rRNA molecule and 33 ribosomal proteins (RPS). Three of the four rRNA molecules (28S, 5.8S, and 18S) are transcribed together as a single precursor rRNA molecule called the 47S pre-rRNA. The 47S pre-rRNA is transcribed by the dedicated RNA polymerase I (Pol I) from ribosomal DNA sequences (rDNA). The human genome contains hundreds of copies of tandem repeats of rDNA sequences distributed across five chromosomes. The rDNA clusters are organized into characteristic regions within the nucleus known as the nucleolus (12) .
Cleavage of the 47S pre-rRNA by processing factors and small nucleolar ribonucleoproteins leads to the formation of the 28S, 5.8S, and 18S rRNA molecules required for small and large subunit assembly. The only rRNA molecule not transcribed in the nucleolus is the 5S rRNA, which is transcribed by RNA polymerase III (Pol III). The 5S rRNA molecules are transported into the nucleolus after synthesis to be assembled with the 28S and the 5.8S rRNA to form the large subunit. The Pol III also is responsible for transcribing transfer RNA (tRNA), which are transported out of the nucleus, loaded with amino acids, and used for polypeptide elongation (12) .
The various ribosomal proteins are encoded by messenger RNA (mRNA), which are transcribed by RNA polymerase II (Pol II). Ribosomal protein mRNA are transported out of the nucleus and translated into protein in the cytoplasm. The mRNA encoding assembly factors and transport proteins also are transcribed by Pol II and transported into the cytoplasm for translation. Ribosomal proteins and protein-processing factors subsequently are imported back into the nucleolus to be assembled onto the small and large subunits. Small subunit ribosomal proteins (RPS) assemble onto the 18S rRNA scaffold, and large subunit ribosomal proteins (RPL) assemble onto the combined 28S, 5S, and 5.8S rRNA scaffold. After assembly, the 40S and 60S subunits are exported out into the cytoplasm, where they bind their respective cofactors. The 40S and 60S subunits do not combine and mature into the functional 80S ribosome until translation initiation occurs on mRNA molecules (12) .
As can be seen from the previous discussion, ribosome biogenesis is a highly complex process with numerous points of regulation. Despite this complexity, the general consensus is that the primary point of regulation in ribosome biogenesis is the transcription of 47S pre-rRNA by Pol I and, in particular, the initiation of transcription (19) . The first step in 47S pre-rRNA transcription is the formation of the preinitiation complex (PIC) by the binding of upstream binding factor (UBF) proteins at the rDNA promoter which, in turn, recruits the selectivity factor 1 (SL-1, also known as TIF-1B) complex. Ribosomal DNA transcription is initiated with the recruitment of Pol I to the PIC via Rrn3 (also known as TIF-1A), which serves as a bridge between SL-1 and Pol1 (19) . The formation and activation of this Pol I regulon is regulated by the extracellular signal-regulated kinase (ERK) and mechanistic target of rapamycin (mTOR) pathways via UBF and Rrn3 phosphorylation (19) . Activation of the mTOR complex 1 (mTORC1) stimulates the UBF-mediated transcription of rRNA as well as the 5′-terminal oligopyrimidine (TOP)-mediated transcription of mRNA encoding ribosomal proteins (24, 31) . Accordingly, blocking mTORC1 activity has been shown to inhibit the translation of the numerous 5′-TOP mRNA encoding ribosomal proteins and impair the formation of Pol I transcription complex in the promoter region of the rRNA gene (15, 17) . In addition to these signaling pathways, numerous studies collectively have provided evidence that the proto-oncogene c-Myc has a central role in the control of ribosome biogenesis through its regulation of all three RNA polymerases and, by extension, their respective gene products such as Pol I regulon components, ribosomal proteins, and 5S rRNA (32) .
Origin of Our Hypothesis
In an effort to identify new genes that have a critical role in skeletal muscle growth, our laboratory has performed a series of transcriptome analyses during the last few years (7, 8, 18) . In addition to identifying a small set of conserved genes that were upregulated during hypertrophy and regrowth after atrophy, we found that there seemed to be a positive relationship between the change in total RNA content of the muscle and the magnitude of muscle growth (7, 8) . During hypertrophic growth, the 62% increase in skeletal muscle mass was associated with a 2.5-fold increase in RNA content, whereas RNA abundance remained stable throughout a period of muscle regrowth in which mass increased by a modest 15% (7) . This apparent relationship between RNA content and muscle growth was further bolstered by our more recent study comparing the hypertrophic response of young and old mice (18) . After 2 wk of synergist ablation, the plantaris muscle of 24-month-old mice showed a significantly blunted hypertrophic response compared with 5-month-old mice that was associated with a 50% increase (compared with a 2.5-fold increase in young mice) in the RNA content of the muscle (18) . Knowing that total RNA can serve as a proxy of ribosome content, this finding suggested that the ability of old muscle to produce new ribosomes in response to a growth stimulus was impaired and, moreover, might be the underlying cause for the decreased hypertrophy. In support of this notion, we reported that the increase in rDNA transcription during hypertrophy was significantly less in old muscle compared with young muscle; after 3 d of synergist ablation, 45S pre-rRNA expression increased threefold in the plantaris muscle of young mice and only 1.7-fold in old mice (18) . Furthermore, after 7 d of synergist ablation, 45S pre-rRNA expression continued to be elevated threefold in the plantaris muscle of young mice but returned to baseline levels in old mice. Collectively, these data provided the impetus for proposing the hypothesis that ribosome biogenesis is necessary for skeletal muscle hypertrophy. In the following sections, we will present evidence from colleagues in the field, as well as studies on cardiac hypertrophy, that support our hypothesis.
Ribosome Biogenesis in Cardiac Hypertrophy
What evidence is there for the necessity of ribosome biogenesis in skeletal muscle hypertrophy? Although most of the evidence supporting this hypothesis has emerged only in the last few years, the cardiac field has a long history investigating the importance of ribosome biogenesis in cardiac hypertrophy. In reviewing the literature, Hannan et al. (16) concluded that increased translational capacity was required for cardiac hypertrophy, and that increased translational efficiency alone was not sufficient to promote cardiac hypertrophy. This conclusion was best exemplified by a study from Brandenburger et al. (6) showing that ribosome biogenesis was required for cardiomyocyte hypertrophy, and that UBF was essential in mediating this process.
Ribosome Biogenesis in Skeletal Muscle Hypertrophy
As previously mentioned, total RNA can be used as a measure of ribosome content given that approximately 85% of the RNA in the cell is rRNA; thus, an increase in RNA content is considered to be indicative of an increase in ribosome biogenesis (39) . This convention is supported by our work and others showing that increases in RNA content during muscle hypertrophy are associated with an increase rDNA transcription as reflected by higher 45S pre-rRNA expression (18, 33) . In the following sections, we will take advantage of this convention to explore what is known about the relationship between ribosome biogenesis and skeletal muscle hypertrophy.
Skeletal Muscle Hypertrophy During Postnatal Development
The rapid growth that occurs during postnatal development is no better characterized than in skeletal muscle. The increase in skeletal muscle size during postnatal development primarily is the result of cell hypertrophy with possibly a small contribution from hyperplasia, an increase in cell number (38) . This hypertrophic growth was described beautifully by White et al. (36) and colleagues who reported a 7.6-fold increase in myofiber cross-sectional area between postnatal day 7 (P7) and adulthood (P56) in the mouse extensor digitorum longus muscle with no change in fiber number; remarkably, more than 40% of this hypertrophic growth happened between P7 and P21. A rich body of early work clearly showed that postnatal skeletal muscle hypertrophy was associated with a significant increase in RNA abundance, and that undernutrition, in the form of a low-protein diet, negatively impacted both the growth and RNA content of the muscle (38) . More recently, Fiorotto et al. (11) provided a detailed description of the effect of undernutrition on postnatal muscle protein metabolism and growth. The recovery of skeletal mass after undernutrition was dependent on the restoration of translational capacity, which coincided with a twofold increase in UBF expression (11) . This study also showed that during normal maturation, there was a progressive decline in both ribosome abundance and UBF expression of the muscle, consistent with the decrease in the fractional growth rate (11) . These studies collectively demonstrate the existence of a strong connection between postnatal skeletal muscle hypertrophy and ribosome content that is sensitive to nutrition.
Hypertrophy in Adult Skeletal Muscle
In addition to our studies, numerous animal (1, 14, 15, 23, 26, 33, 35) , human (3, 9, 10, 25, 27, 29, 30) , and in vitro (24) studies have provided further evidence that skeletal muscle hypertrophy is associated with an increase in ribosome biogenesis. The following section will provide a brief overview of these studies with an emphasis on those findings that support our hypothesis that ribosome biogenesis is necessary for skeletal muscle hypertrophy.
One of the first studies to really investigate the importance of ribosome biogenesis and skeletal muscle hypertrophy was a study by Nader et al. (24) . Using an in vitro model of hypertrophy, the authors showed an increase of approximately 70% in rRNA 48 h postserum stimulation that was associated with increased UBF availability as the result of cyclin D1-dependent activation of CDK4 phosphorylation of Rb (24) . When the mTORC1 activity was inhibited by rapamycin during serum stimulation, the subsequent increases in UBF availability and rRNA abundance were not observed which, in turn, was associated with a complete loss of myotube hypertrophy (24) . This is a critical finding because it suggests that the ribosomal pool is limiting and must be expanded to support myotube hypertrophy. In agreement with this finding, Stec et al. (29) reported that the specific inhibition of Pol I activity by CX-5461 treatment prevented a serum-stimulated increase in total RNA as well as myotube hypertrophy. Moving into the mouse, the Nader laboratory next investigated Pol1 regulon expression during the initial phase of hypertrophy induced by synergist ablation (33) . After 3 d of synergist ablation, there was a twofold increase in total RNA concentration as the result of a threefold increase in 45S pre-rRNA expression. The increase in rRNA expression was paralleled by an increase of approximately 2.5-to 6-fold in the transcript levels of Pol I regulon components such as Polr1b, Rrn3 (TIF-1A), Polr1e (PAF53), Ttf1, and Taf1c as well as UBF mRNA and protein. Consistent with the upregulation of the Pol I regulon, a chromatin immunoprecipitation assay showed enhanced binding of Pol I and UBF at the rDNA promoter. The findings from these studies provide clear evidence that in response to a hypertrophic stimulus, there is a dramatic increase in translational capacity of the muscle as the result of Pol 1-dependent transcription of rDNA.
In an effort to clarify how increases in translational efficiency and capacity are related to the degree of muscle hypertrophy, Nakada et al. (26) modified the synergist ablation model in such a way as to produce four different levels of hypertrophy. After 5 d of synergist ablation, the plantaris muscle weight increased by 8%, 22%, 32%, and 45% with rRNA content increasing by 1.8-fold, 2.2-fold, and 2.5-fold in only the top three groups, respectively. Furthermore, the increase in translational capacity observed at 5 d was strongly correlated (r = 0.98) to muscle weight after 14 d of synergist ablation. In contrast, the level of p70 S6K phosphorylationreadout of mTORC1 activation and translation efficiencyshowed no further increase above 20% hypertrophy leading the authors to conclude that increased translational capacity was required for robust hypertrophic growth (26) .
Although the synergist ablation model of hypertrophy has been very useful in identifying the cellular and molecular mechanisms regulating skeletal muscle hypertrophy, there are concerns that it may not accurately reflect the underlying processes involved in the hypertrophic response after resistance exercise (5, 21) . To better mimic resistance exercise, a rodent model of electrical stimulation was developed and successfully used in the first study to report elevated p70 S6K phosphorylation after high-force contractions (2, 37) . This model of hypertrophy was used recently by West et al. (35) to better understand the influence of mTORC1 signaling on translational capacity after an acute bout of resistance exercise. Transcription of rDNA was increased between 12 and 36 h after exercise and preceded the trend toward increased translational capacity. In agreement with the in vitro findings of Nader et al., the inhibition of mTORC1 signaling by rapamycin completely prevented the increase in ribosome biogenesis; however, the increase in c-Myc and UBF phosphorylation after electrical stimulation were rapamycin-insensitive suggesting these two pathways may work together in a temporal fashion to promote ribosome biogenesis. In support of this notion, the Hornberger laboratory reported that the increase of approximately threefold in translational capacity after 7 d of synergist ablation was not blocked completely by rapamycin treatment but only blunted by 32% (14) . Furthermore, the significant increase in both UBF protein and Rb hyperphosphorylation levels at this later time point was insensitive to mTORC1 inhibition. More recently, Goodman et al. (13) provided intriguing evidence showing that yes-associated protein 1 (YAP) was capable of driving c-Myc expression in a rapamycin-independent manner. Similar to what has been described in cardiac hypertrophy, it seems that mTORC1 regulation of translational efficiency is important in mediating the initial events of ribosome biogenesis, and that more long-term c-Myc regulation of ribosome biogenesis may be necessary to sustain a full hypertrophic response (16) . Furthermore, the early activation mTORC1 also may be necessary to ensure robust c-Myc protein expression because inhibition of mTORC1 activity by rapamycin has been shown to reduce the amount of c-Myc mRNA associated with the polysome (34) . The proposed temporal relationship between translational efficiency and capacity during skeletal muscle hypertrophy is shown graphically in the Figure. How well do the findings on ribosome biogenesis using animal models of hypertrophy translate into what is observed in humans after an acute bout of RE and with RE training? Nader et al. (25) conducted a study to determine if the change in gene expression after an acute bout of RE was altered after 12 wk of RE training. Relevant to the current discussion, these investigators found that both c-Myc and 45S pre-rRNA expression were significantly elevated in response to RE regardless of training status; however, in the trained state, these genes were less responsive to RE, with 45S pre-RNA expression significantly attenuated by 40% and c-Myc expression slightly, though still significant, above control levels (25) . Although these findings are somewhat limited, they do suggest that the response to RE in terms of ribosome biogenesis is conserved between humans and rodents.
Building on the findings of Nader et al., Figueiredo et al. (9, 25) performed the first detailed human study investigating the regulation of ribosome biogenesis in response to RE, both acutely and after 8 wk of RE training. The total RNA concentration after training tended toward an increase (1.3-fold) but did not achieve statistical significance because of variability between subjects; however, the increase in total RNA from pretraining to posttraining was significantly correlated (r = 0.72) to the percent change in the cross-sectional area of the muscle (9) . Consistent with this trend, 45S pre-rRNA expression in resting muscle was increased by twofold after training and reflected in a two-to fourfold increase in mature 18S, 5.8S, and 28S rRNA. The activation of mTORC1 and ERK signaling pathways remained responsive to exercise independent of training status as well as cyclin D1 and UBF proteins and Rrn3 (TIF-1A) Ser 649 phosphorylation (9) . Although UBF phosphorylation did change after exercise, UBF Ser 388 phosphorylation was approximately fivefold higher in the rested state after 8 wk of RE training, which the authors speculated was necessary for the increased translational capacity observed in trained muscle.
In a recent follow-up study, Figueiredo et al. (10) investigated the impact of different recovery strategies on ribosome biogenesis after an acute bout of RE. To provide an important temporal component to the study, muscle biopsies were collected at 2, 24, and 48 h postexercise. This time course allowed the authors to capture activation of the upstream p38/MNK/ eIF4E signaling cascade because p38 Thr180/Tyr182 , MNK1 Thr197 , and eIF4E Ser209 phosphorylation were all elevated significantly at 2 h postexercise (10) . Furthermore, UBF Ser388 phosphorylation, 45S pre-rRNA, and c-Myc expression were increased significantly at both the 24-h and 48-h postexercise time point (10) . Collectively, these data provide convincing evidence that ribosome biogenesis is activated in response to a single bout of RE in humans.
Although the studies by Figueiredo et al. clearly showed that ribosome biogenesis occurs after RE, the findings of their studies do not speak about whether ribosome biogenesis is necessary for skeletal muscle hypertrophy in humans. A study by the Bamman laboratory reported that in older individuals (age, 60-75 yr), only extreme responders (to 4 wk of RE) showed a significant increase in total RNA (+26%) and rRNA content (+40%), which was associated with an increase of approximately 350% in c-Myc protein (29) . These findings were not completely unexpected given this group's earlier study showing blunted ribosome biogenesis in older individuals after a bout of RE, in agreement with the study of Kirby et al. (18, 30) comparing the hypertrophic response of young and old mice. A curious difference not observed in older mice was the significantly greater ribosome content of skeletal muscle from older humans presumably as a result of higher 45S pre-rRNA expression (18, 30) . The reason why older human skeletal muscle has more ribosomes remains unknown, but the authors speculate that it may reflect some type of compensatory mechanism for impaired translational efficiency known to occur with aging (30) . Although these findings do not demonstrate definitively that skeletal muscle hypertrophy requires ribosome biogenesis, they do show that the hypertrophic response is enhanced by increases in translational capacity.
An unanswered question is if the reported increase in rRNA abundance after RE truly results in the production of more functional ribosomes? While this question remains to be answered, Srivastava et al. (28, 38) reported that changes in total RNA during skeletal muscle maturation were strongly correlated with the level of polysome formation suggesting that the increase in rRNA observed with hypertrophy is indicative of more functionally active ribosomes. This issue takes on greater importance given that skeletal muscle from older humans was shown to have a higher concentration of total RNA compared with young skeletal muscle, begging the question as to whether this actually indicates a higher translation capacity (30) .
SUMMARY
The results of studies from our laboratory, as well as other investigators in the field, have shown clearly that ribosome biogenesis is increased in response to RE, and that this response is conserved across species and affected in a similar manner with aging. Moreover, there is a strong correlation between the level of ribosome biogenesis and the magnitude of hypertrophy that also is conserved in both humans and rodents. Although the findings of these studies collectively make a strong argument for the necessity of ribosome biogenesis in skeletal muscle hypertrophy, they remain descriptive in nature. The challenge for the field moving forward will be to carry out in vivo lossand gain-of-function experiments with components of the Pol I regulon and master regulators (such as c-Myc) to rigorously test the hypothesis that ribosome biogenesis is necessary for skeletal muscle hypertrophy. The results of such experiments are expected to show that both translational efficiency and capacity serve critical roles in the regulation of skeletal muscle hypertrophy.
